Comparison of tailored and empiric scan delays for CT angiography of the abdomen

A Triphasic Split-bolus Contrast Injection Protocol for Artery-vein Separation During Pulmonary Computed Tomographic Angiography

PURPOSE

Accurate artery-vein separation on pulmonary computed tomographic (CT) angiography is desirable for preoperative 3-dimensional image simulation, while using a minimal amount of contrast medium. This study aimed to verify whether a split-bolus contrast enhancement protocol with test-bolus tracking would provide contrast differentiation between the pulmonary arteries (PA) and pulmonary veins (PV) during high-pitch single-pass CT angiography.

MATERIALS AND METHODS

Fifty patients underwent pulmonary CT angiography with a triphasic split-bolus injection protocol with the main bolus of contrast medium for 6 seconds, followed by a subsequent bolus of 20% diluted contrast medium/80% saline for another 6 seconds and a 5-second saline chaser. The single-scan timing was individually tailored to the peak enhancement at the left atrium, that is, the pulmonary-venous dominant phase, by monitoring a time-enhancement curve with test bolus.

RESULTS

Time-enhancement curves of the test bolus demonstrated that the interval times between the peak enhancements at the PA and PV were ~6 seconds. For contrast enhancement image analyses with our protocol, the attenuation measurements at the main PA and left atrium were performed. The mean (SD) CT numbers were 246.4 (50.0) HU at the main PA, and 410.8 (59.0) HU at the left atrium. The mean difference in the CT numbers was 164.4 HU (95% confidence interval: 149.2-179.6, P <0.001) between the main PA and left atrium.

CONCLUSIONS

Our contrast enhancement protocol for high-pitch single-pass pulmonary CT angiography could provide the desired artery-vein separation while maintaining adequate attenuations of the pulmonary vasculature.

Low contrast volume dual-energy CT of the chest: Quantitative and qualitative assessment

PURPOSE

To evaluate the image quality of chest CT performed on dual-energy scanners using low contrast volume for routine chest (DECT-R) and pulmonary angiography (DECTPA) protocols.

MATERIALS AND METHODS

This retrospective study included dual-energy CT scans of chest performed with low contrast volume in 84 adults (34M:50F; Age 69 ± 16 years: Weight 71 ± 16kg). There were 42 patients with DECT-R and 42 patients with DECT-PA protocols. Images were reviewed by two thoracic radiologists. Qualitative assessment was done on a four-point scale, for subjective assessment of contrast enhancement and artifacts (1 = Excellent, 2 = optimal, 3 = suboptimal, and 4 = Limited) in the pulmonary arteries and thoracic aorta, on virtual monoenergetic and material decomposition iodine (MDI) images. Quantitative assessment was performed by measuring the CT (Hounsfield) units in aorta and pulmonary arteries. The estimated glomerular filtration rate (eGFR) was calculated before and after CT scans. Two tailed student's t-test was performed to assess the significance of findings, and strength of correlation between readers was determined by Cohen's kappa test.

RESULTS

DECT-PA and DECT-R demonstrated excellent/adequate contrast density within the pulmonary arteries (up to segmental branch), and aorta. There was no suboptimal or limited examination. There was strong interobserver agreement for arterial enhancement in pulmonary arteries (kappa = 0.62-0.89) and for thoracic aorta (kappa = 0.62-0.94). Pulmonary emboli were seen in 3/42(7%) in DECT-R and in 5/42(12%) in DECT-PA. There was no significant change in eGFR before and after IV contrast injection (p = 0.46-0.52).

CONCLUSION

DECT-R and DECT-PA performed with low contrast volume provide diagnostic quality opacification of the pulmonary vessels and aorta vessels.

An optimized test bolus for computed tomography pulmonary angiography and its application at 80 kV with 10 ml contrast agent

Computed tomography pulmonary angiography (CTPA) is usually used for pulmonary embolism (PE) detection. However, the determination of scan timing remains a challenge due to the short scan duration of CTPA. We aimed to develop an optimized test bolus to determine scan delay in CTPA. The time-enhancement curves were obtained by measuring the enhancement within a region of interest in the main pulmonary artery and vein. A total of 70 patients were randomly divided into two groups (n = 35 each): the control group underwent CTPA using the test bolus approach and the test group underwent CTPA using the biphasic time-enhancement curves approach. Tube voltages of 100 kVp and 80 kVp and 20 ml and 10 ml contrast agent were adopted in the control and test groups, respectively. The CT numbers, image quality, PE detection was evaluated. There was a point of intersection between the pulmonary artery and vein test bolus enhancement curves. The scan delay time (T_DELAY) was obtained based on the time at intersection (T_CROSS) and the scan duration (T_SD): T_DELAY = T_CROSS − T_SD. The mean CT numbers for pulmonary vein in the control were higher than those in the test group (all p < 0.001). The image quality for the pulmonary arteries in the test group was better than that in the control group (p < 0.01), with artifact reduction in the superior vena cava. Segmental PE could be detected using the optimized protocol. The radiation dose and iodine load in the test group were all lower than those in the control (p < 0.01). We established an approach to calculate the scan delay of CTPA, and this approach could be used for CTPA at 80 kVp with 10 ml contrast agent.

Computed Tomography Angiography in Peripheral Arterial Disease: Comparison of Three Image Acquisition Techniques to Optimize Vascular Enhancement-Randomized Controlled Trial

Objectives: To prospectively compare three image acquisition techniques in lower extremity CT angiography: the “standard” anterograde technique (SA), the adaptive anterograde technique (AA), and the retrograde acquisition technique (RA).

Materials and Methods: Sixty consecutive patients were prospectively enrolled and randomized into three acquisition groups: 20 patients were evaluated with SA, 20 with AA as described by Qanadli et al., and 20 with caudocranial acquisition from the feet to the abdominal aorta (RA). Quantitative image quality was assessed by measuring the intraluminal attenuation at different levels of interest, with a total of 536 levels. Qualitative image quality was assessed by two radiologists in consensus using a Likert scale to rate the arterial enhancement and venous return. For each patient and limb, the presence of occlusive or aneurysmal disease was documented.

Results: In quantitative analysis, RA showed lower attenuation values than SA and AA (p < 0.01). AA showed the highest and most homogeneous attenuation along the arterial tree. In qualitative analysis, AA had the lowest rate of non-diagnostic vascular segments (3.9%) compared to SA and RA (4.7 and 13.1%, respectively, p < 0.01). The influence of venous return was significantly different among the different techniques; venous contamination was particularly prevalent at the aortic level with RA (9.4% of patients, 0% with SA and AA, p < 0.01). The presence of stenosis or occlusion had no significant influence on the attenuation values across all levels and acquisition techniques. Conversely, the presence of aneurysmal disease had a significant effect on the luminal attenuation in AA (higher attenuation) and RA (lower attenuation) at the iliac (p = 0.03 and 0.04, respectively) and femoral levels (p = 0.02 and <0.01, respectively).

Conclusion: Considering both quantitative and qualitative analysis, AA performed better than SA and RA, providing the highest percentage of optimal vascular enhancement. AA should be recommended as the technique of choice, specifically in the presence of aneurysmal disease. Alternatively, SA can be useful in case of renal failure, as the test bolus is unnecessary. Finally, the increasing availability of fast CT systems will likely overcome the limitations of RA.

Clinical evaluation of a novel multibolus contrast agent injection protocol for thoraco-abdominal CT angiography: Assessment of homogeneity of arterial contrast enhancement

PURPOSE

To evaluate the in vivo feasibility of a multibolus contrast agent (CA) injection protocol with a reduced CA volume for thoraco-abdominal CT angiography (CTA) and to compare it to a single-bolus CA injection protocol.

METHOD

63 patients who underwent CTA with the multibolus protocol (60 ml CA) were divided in two groups either without (group 1, n = 48) or with (group 2, n = 15) aortic dissection. The aortic contrast enhancement was measured in group 1 using manual ROI analysis (10 segments), as well as semi-automated linear attenuation profiles. A subgroup (n = 18) of group 1, who also underwent imaging with the single-bolus protocol (94 ml CA), was used to compare both protocols. In group 2, differences in attenuation of the true and the false lumen for both the single- and the multibolus protocol were assessed with ROI attenuation measurements in both lumina. Comparisons were made using Wilcoxon test.

RESULTS

Average attenuation was above 200 HU for 98 % of cases using the multibolus protocol. There was superior contrast homogeneity for the multibolus protocol with a lower standard deviation of attenuation values along the length of the scan (p = 0.003), while average attenuation was higher for the single-bolus protocol (p = 0.002). Prolonged enhancement plateau lead to a more uniform opacification of the true and the false lumen in patients with aortic dissection using the multibolus protocol (p = 0.012).

CONCLUSIONS

The multibolus protocol in thoraco-abdominal CTA is feasible in patients. It shows consistently high arterial enhancement with superior contrast homogeneity compared to a single-bolus protocol in patients with and without aortic dissection.

Performance of a simple robust empiric timing protocol for CT pulmonary angiography

OBJECTIVE

We instituted a new, simple CT pulmonary angiography (CTPA) contrast material timing protocol using a standard empiric delay to replace our previous timing bolus method. This study tests the hypothesis that the empiric protocol more consistently produces diagnostic quality images of both the pulmonary arteries and the aorta with lower radiation exposure.

MATERIALS AND METHODS

We performed a retrospective review of consecutive CTPAs for 2months both before and after the protocol change. Pulmonary artery and aortic enhancement, patient characteristics, radiation exposure and results of CTPA were analyzed.

RESULTS

There were 182 patients in the timing bolus group and 164 in the empiric timing group. Both groups had a female majority (59%) and a similar mean age (58 and 57years, respectively). Enhancement was significantly higher both for the pulmonary artery (median 400HU versus 359HU, P<0.001) and aorta (median 381HU versus 218HU, P<0.01) in the empiric timing group versus the timing bolus group, respectively. Radiation exposure was lower (5.3mSv versus 6.0mSv, P=0.05) in the empiric timing group, despite a higher body-mass-index (31 versus 29kg/m², P<0.01). Pulmonary embolism positivity rate was non-significantly higher in the timing bolus vs the empiric timing group (19% and 13%, P=0.1).

CONCLUSION

A simple empiric timing protocol for CTPA has robust performance compared to a timing bolus protocol. Empiric timing preserves the required high diagnostic quality for evaluation of the pulmonary arteries with the added benefits of aortic enhancement and lower radiation exposure.

Optimal scan delay depending on contrast material injection duration in abdominal multi-phase computed tomography of pancreas and liver in normal Beagle dogs

This study was conducted to establish the values for optimal fixed scan delays and diagnostic scan delays associated with the bolus-tracking technique using various contrast material injection durations in canine abdominal multi-phase computed tomography (CT). This study consisted of two experiments employing the crossover method. In experiment 1, three dynamic scans at the porta hepatis were performed using 5, 10 and 15 sec injection durations. In experiment 2, two CT scans consisting of five multi-phase series with different scan delays of 5 sec intervals for bolus-tracking were performed using 5, 10 and 15 sec injection duration. Mean arrival times to aortic enhancement peak (12.0, 15.6, and 18.6 sec for 5, 10, and 15 sec, respectively) and pancreatic parenchymal peak (17.8, 25.1, and 29.5 sec) differed among injection durations. The maximum mean attenuation values of aortas and pancreases were shown at the scan section with 0 and 5, 0 and 10 and 5 and 10 sec diagnostic scan delays during each injection duration, respectively. The optimal scan delays of the arterial and pancreatic parenchymal phase in multi-phase CT scan using fixed scan delay or bolus-tracking should be determined with consideration of the injection duration.

Contrast medium administration and image acquisition parameters in renal CT angiography: what radiologists need to know

Over the last decade, exponential advances in computed tomography (CT) technology have resulted in improved spatial and temporal resolution. Faster image acquisition enabled renal CT angiography to become a viable and effective noninvasive alternative in diagnosing renal vascular pathologies. However, with these advances, new challenges in contrast media administration have emerged. Poor synchronization between scanner and contrast media administration have reduced the consistency in image quality with poor spatial and contrast resolution. Comprehensive understanding of contrast media dynamics is essential in the design and implementation of contrast administration and image acquisition protocols. This review includes an overview of the parameters affecting renal artery opacification and current protocol strategies to achieve optimal image quality during renal CT angiography with iodinated contrast media, with current safety issues highlighted.

Contrast material and radiation dose reduction strategy for triple-rule-out cardiac CT angiography: feasibility study of non-ECG-gated low kVp scan of the whole chest following coronary CT angiography

BACKGROUND

Dedicated coronary computed tomography (CT) scan has been proven to be an accurate diagnostic modality in evaluating coronary artery disease. A second phase scan starting immediately after the coronary CT scan might enable visualization of the different vascular territories of the entire chest.

PURPOSE

To investigate the feasibility of a contrast material and radiation dose reduction triple-rule-out (TRO) CT angiography (CTA) protocol with serial non-ECG-gated low kVp scan of the whole chest, which utilizes a recirculated contrast agent.

MATERIAL AND METHODS

Thirty patients were scanned with the new TRO-CTA protocol; after the coronary scan with retrospective ECG-gating, non-ECG-gated whole-chest CTA was performed at 80 kVp to evaluate aortic arch (AAr) and pulmonary trunk (PT). Another 30 patients were scanned by our conventional TRO-CTA protocol at 120 kVp with retrospective ECG-gating. We compared the estimated effective dose (ED), contrast material (CM) dose, contrast-to-noise ratio (CNR) of the ascending aorta (AAo), and the rate of patients who could achieve adequate attenuation of the AAr and PT between the two protocols.

RESULTS

The total ED of the new TRO-CTA protocol was 29.6% lower than that of the conventional protocol (P < 0.01). The amount of CM used for the new TRO-CTA protocol was significantly lower than in the conventional protocol (60.1 ± 9.6 mL vs. 91.8 ± 22.6 mL, P < 0.01). The CNR of the AAo was 30.2% higher with the new TRO-CTA protocol than with the conventional protocol (P < 0.01). There was no significant difference in the success rate of adequate attenuation of the AAr and PT between the two protocols (P > 0.05).

CONCLUSION

The new TRO-CTA protocol can reduce the total dose of radiation and the contrast dose and yield adequate vascular enhancement compared with the conventional protocol.

Use of high-concentration contrast media in multiple-detector-row CT: principles and rationale

Contrast-medium-enhanced multiple-detector-row CT (MDCT) is a powerful technique for vascular and hepatic imaging. With increasingly faster acquisition speeds, which have become possible with latest 8- and 16-channel scanner systems, contrast medium delivery is becoming increasingly difficult. This article reviews the pharmacokinetic and physiologic principles of vascular and hepatic enhancement following the intravenous injection of iodinated contrast medium. The effects of user-selectable injection parameters, such as the injection rate, the injection duration, and the contrast medium concentration on arterial and parenchymal enhancement are elucidated. Equipped with this knowledge, rational injection strategies for CT angiographic protocols for scanners with different acquisition speeds are derived. Furthermore, injection and timing protocols, optimized for hepatic MDCT during the early arterial, late arterial, and parenchymal phases, are developed.

The comparison of bolus tracking and test bolus techniques for computed tomography thoracic angiography in healthy beagles

Computed tomography thoracic angiography studies were performed on five adult beagles using the bolus tracking (BT) technique and the test bolus (TB) technique, which were performed at least two weeks apart. For the BT technique, 2 mL/kg of 300 mgI/mL iodinated contrast agent was injected intravenously. Scans were initiated when the contrast in the aorta reached 150 Hounsfield units (HU). For the TB technique, the dogs received a test dose of 15% of 2 mL/kg of 300 mgI/mL iodinated contrast agent, followed by a series of low dose sequential scans. The full dose of the contrast agent was then administered and the scans were conducted at optimal times as identified from time attenuation curves. Mean attenuation in HU was measured in the aorta (Ao) and right caudal pulmonary artery (rCPA). Additional observations included the study duration, milliAmpere (mA), computed tomography dose index volume (CTDI[vol]) and dose length product (DLP). The attenuation in the Ao (BT = 660 52 HU ± 138 49 HU, TB = 469 82 HU ± 199 52 HU, p = 0.13) and in the rCPA (BT = 606 34 HU ± 143 37 HU, TB = 413 72 HU ± 174.99 HU, p = 0.28) did not differ significantly between the two techniques. The BT technique was conducted in a significantly shorter time period than the TB technique (p = 0.03). The mean mA for the BT technique was significantly lower than the TB technique (p = 0.03), as was the mean CTDI(vol) (p = 0.001). The mean DLP did not differ significantly between the two techniques (p = 0.17). No preference was given to either technique when evaluating the Ao or rCPA but the BT technique was shown to be shorter in duration and resulted in less DLP than the TB technique.

Intravenous contrast medium administration and scan timing at CT: considerations and approaches

The continuing advances in computed tomographic (CT) technology in the past decades have provided ongoing opportunities to improve CT image quality and clinical practice and discover new clinical CT imaging applications. New CT technology, however, has introduced new challenges in clinical radiology practice. One of the challenges is with intravenous contrast medium administration and scan timing. In this article, contrast medium pharmacokinetics and patient, contrast medium, and CT scanning factors associated with contrast enhancement and scan timing are presented and discussed. Published data from clinical studies of contrast medium and physiology are reviewed and interpreted. Computer simulation data are analyzed to provide an in-depth analysis of various factors associated with contrast enhancement and scan timing. On the basis of basic principles and analysis of the factors, clinical considerations and modifications to protocol design that are necessary to optimize contrast enhancement for common clinical CT applications are proposed.

[Technological advances in cardiac CT]

The SFR-SFC presents guidelines dedicated to cardiac and coronary imaging using CT in the area of indications, technological requirement including both hardware and software, patient conditioning, CT protocols and related results concerning radiation dose, image quality and diagnostic value. These guidelines are based either on up-dated medical literature proofs and/or on expert consensus.

Multiple-detector computed tomographic angiography of pancreatic neoplasm for presurgical planning: comparison of low- and high-concentration nonionic contrast media

OBJECTIVE

To evaluate the degree of contrast enhancement, image quality, and accuracy of predicting resectability of pancreatic neoplasm with 16-row multiple-detector computed tomography (MDCT) angiography using low- and high-concentration (300 and 370 mg of iodine per milliliter, respectively) contrast media (CMs).

MATERIALS AND METHODS

Forty patients who had undergone pancreatic CT angiography (CTA) on 16-MDCT scanner and had surgery were included. Contrast medium of 2 iodine concentrations (group A, 300 mg/mL, n = 20; group B, 370 mg/mL, n = 20) from the same vendor (Isovue; Bracco Diagnostics), with iodine dose of 550 to 600 mg/kg of body weight, was injected at a rate of 5 mL/s. Dual-phase 16-row MDCT was performed using 1.25- and 5-mm collimation for the arterial and portal phases, respectively. For the quantitative analysis, Hounsfield units values in the aorta, superior mesenteric artery, portal vein, and pancreas during arterial and venous phases were measured. Two readers subjectively rated the overall image enhancement, 3-dimensional image quality, and lesion and pancreatic duct conspicuity. Accuracy of lesion resectability was also established for each patient. The data were compared using Student t test for statistical analysis.

RESULTS

The quantitative analysis for the degree of enhancement (Hounsfield unit) of the aorta, superior mesenteric artery, and pancreas during the arterial phase demonstrated similar values in groups A (low-concentration CM) and B (high-concentration CM), with no statistically significant difference with each other (P > 0.05). During the portal venous phase, we found superior enhancements in the superior mesenteric and portal veins in group A (P < 0.05). The qualitative assessments of the overall image enhancement and 3-dimensional image quality on a 5-point scale were 4.3 and 4.65, respectively (P < 0.05), in group A and 4.6 and 4.75, respectively, in group B, whereas on a 3-point scale, the pancreatic duct display and lesion conspicuity were 2.75 and 2.85, respectively, in group A and 2.9 and 2.9, respectively, in group B. The accuracy for lesion resectability was 95% (19/20) in group A and 100% (20/20) in group B (P > 0.05).

CONCLUSION

Both CMs demonstrated comparable performance for 16-row MDCT of the pancreas for presurgical planning. However, high-concentration CM (370 mg of iodine per milliliter) provides higher overall enhancement and superior-quality 3-dimensional images with a shorter injection duration.

Optimization of cardiac MSCT contrast injection protocols: dependency of the main bolus contrast density on test bolus parameters and patients' body weight

RATIONALE AND OBJECTIVES

Our aim was to evaluate the correlation of test bolus (TB) curve parameters with main bolus (MB) contrast density for cardiac 16-slice computed tomography, and to correlate observed enhancement with patient body weight.

MATERIALS AND METHODS

Sixty patients with known or suspected coronary artery disease were included in a prospective double-blind study. Contrast material containing 300 mg iodine/mL (Iomeprol 300; Imeron 300, Bracco Imaging SpA, Milan, Italy) and 400 mg iodine/mL (Iomeprol 400; Imeron 400) was injected at a rate of 1 g of iodine/second. Contrast densities (Hounsfield units) of the MB were determined in the left cardiac system. The peak density (PD) of maximum attenuation and the area under the curve (AUC) of the TB curve were calculated for each patient. The dependency of MB contrast attenuation on these parameters and on patient body weight was evaluated.

RESULTS

Positive correlations (r = 0.52 and r = 0.56, respectively; P < .0001) were obtained between the PD and AUC of the TB curve with the mean density of the MB. Stronger correlations (r = 0.63 and r = 0.64, respectively; P < .0001) between PD and AUC of the TB curve and MB attenuation were found when patient body weight was included in the analysis.

CONCLUSIONS

Strong correlation of the PD and AUC of the TB curve with the mean density of the MB is observed when patient body weight is considered. Contrast injection protocols may be optimized, and variations of MB contrast density in the left ventricle and main coronary arteries reduced, by taking these TB parameters and the weight of the patient into account.

Imaging Techniques for Detection and Management of Endoleaks after Endovascular Aortic Aneurysm Repair1

Endovascular aortic aneurysm repair (EVAR) is evolving into a viable alternative to open surgical repair for many patients with abdominal and thoracic aortic aneurysms. Endoleak development is a complication of EVAR and represents one of the limitations of this procedure. Endoleaks represent blood flow outside the stent-graft lumen but within the aneurysm sac. Lifelong imaging surveillance of patients after EVAR is critical to detect endoleaks for the patient's benefit and to determine the long-term performance of the stent-graft. Although computed tomographic angiography is the most commonly used examination for imaging surveillance, magnetic resonance angiography, ultrasonography, and digital subtraction angiography all have a role in endoleak detection and management. This review will focus on imaging techniques used for endoleak detection and the role imaging surveillance plays in the overall care of the post-EVAR patient.

Prediction of aortic peak enhancement in monophasic contrast injection protocols at multidetector CT: phantom and patient studies

PURPOSE

The aim of this study was to investigate whether it is possible to predict aortic peak enhancement (APE) from the contrast dose and injection rate.

MATERIALS AND METHODS

We first undertook an experimental study using a flow phantom that simulates the human circulation. We delivered 90-150 ml of iomeprol-350 at various injection rates and measured the APE values of the simulated aorta. In our clinical study we randomized 20 patients into four groups. In groups A, B, and C the iodine dose per kilogram of body weight (BW) ranged from 450 to 600 mg, and the injection duration was fixed at 30 s; group D received 450 mg/kg over 25 s. We then measured APE in all patients at the whole aorta, averaged the three highest values, and took the result as APE.

RESULTS

In the phantom study, the decision coefficient for the best-fit equation obtained by multiple regression analysis of the relation between the iodine dose and injection rate and the simulated APE was high (0.93). In the patient study, the predicted APE values almost corresponded with the averaged APE values when we applied the fitness equation.

CONCLUSION

Using our fitness equation, APE on contrast-enhanced computed tomography can be predicted from the iodine dose and the contrast injection rate per patient weight.

Lower tube voltage reduces contrast material and radiation doses on 16-MDCT aortography

OBJECTIVE

The purpose of our study was to compare aortic CT angiography performed at a low tube voltage and reduced dose of contrast material with standard-voltage, standard-contrast-dose CT angiography.

SUBJECTS AND METHODS

We evaluated 74 patients for aortic disease on MDCT angiography (collimation, 16 x 1.5 mm; beam pitch, 0.9). In 36 patients, we used the standard tube voltage (120 kVp) and a contrast dose of 100 mL (300 mg I/mL) (protocol 1), and in the remaining 38 patients we applied a reduced tube voltage (90 kVp) and a contrast dose of 40 mL (300 mg I/mL) (protocol 2). The patients' weights, CT attenuation of the aorta, visualization of the celiac axis and renal artery, and graininess and streak artifacts on transverse CT scans were evaluated and recorded for each data set. The signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) were also measured. For statistical analysis, we used the two-tailed Student's t test and logistic regression; agreement between measurements recorded independently by two blinded reviewers was assessed using Cohen kappa statistics.

RESULTS

In both protocols a negative correlation was seen between patient weight and CT attenuation. In three protocol 1 patients weighing more than 70 kg, CT attenuation was less than 200 H. No difference was seen between the two protocols with respect to mean attenuation of the aorta (p = 0.13) or visualization of the celiac axis and renal artery (p = 0.35 and 0.60, respectively). Although the SNR and CNR were significantly higher in protocol 1 than in protocol 2, qualitative evaluation of graininess and streak artifacts showed no statistically significant difference (p = 0.15 and 0.48, respectively). Interobserver agreement for quality assessments was within an acceptable range (kappa = 0.42-0.80).

CONCLUSION

Low-contrast and low-voltage scans are appropriate for lighter patients (< 70 kg in body weight) with aortic disease. Moreover, this method is particularly valuable for follow-up studies of heavier patients (> 70 kg) with renal dysfunction.

Tools of the Trade for CTA: MDCT Scanners and Contrast Medium Injection Protocols

The introduction of multi-detector row computed tomography (MDCT) scanners in 1998 ushered in new advances in CT angiography (CTA). The subsequent expansion of MDCT scanner capabilities, coupled with advances in understanding of contrast medium (CM) dynamics, has further improved the clinical availability and consistency of CTA. We will review recent advances in CT scanner technology and discuss early CM dynamics. Specifically, we describe an approach tailored to the available scanner technology and to patient size aimed at providing consistently robust CTA studies across all vascular territories. A rational method to design combined CTA scan/injection protocols to facilitate this goal will be described. Our current experience with a simplified protocol for CTA with 64-MDCT will also be explained.

CT depiction of small arteries in the pancreatic head: assessment using coronal reformatted images with 16-channel multislice CT

BACKGROUND

To assess the capabilities of 16-channel multislice CT in acquiring almost exclusively arterial-phase images of the pancreas and depicting small pancreatic arteries in coronal reformatted images.

MATERIALS AND METHODS

In 45 consecutive patients, arterial-phase contrast enhancement was measured in the aorta and its branches, portal venous system, and pancreas. Coronal reformatted images of 1.2- or 1.3-mm slice thickness at 0.8- or 0.9-mm intervals were generated from axial images acquired with 0.5-mm collimation. Two radiologists evaluated the quality of imaging in the arterial phase and the visibility of the pancreatic arteries in coronal reformatted images.

RESULTS

Mean enhancement in the aorta and its branches was greater than 300 HU, while that in the portal venous system and pancreas was less than 100 HU. The images were judged to be suitable for delineating the pancreatic arteries in all patients. The following arteries were visualized: anterior superior pancreaticoduodenal (39 patients), posterior superior pancreaticoduodenal (41), anterior inferior pancreaticoduodenal (39), posterior inferior pancreaticoduodenal (33), dorsal pancreatic (42), its right branch (34), and transverse pancreatic (37).

CONCLUSION

Multislice CT can depict small pancreatic arteries using coronal reformatted images generated from almost exclusively arterial-phase axial images acquired with 0.5-mm collimation.

The Effect of Patient Age on Contrast Enhancement During CT of the Pancreatobiliary Region

OBJECTIVE

The objective of our study was to assess whether it is possible to reduce the dose and rate of contrast material injection in elderly patients in triple-phase contrast-enhanced CT of the pancreatobiliary region with an MDCT scanner.

SUBJECTS AND METHODS

One hundred twelve patients were divided into three groups: contrast injection at 0.08 mL/kg body weight/s (an upper limit of 5 mL/s) over 30 seconds in patients 60 years old or younger (group 1, n = 49), the same contrast injection as group 1 in patients more than 60 years old (group 2, n = 32), and contrast injection at 0.07 mL/kg body weight/s (an upper limit of 4.5 mL/s) over 30 seconds in patients more than 60 years old (group 3, n = 31). Contrast enhancement in the aorta, portal venous system, pancreas, and liver was assessed quantitatively. Two radiologists blinded to the patients' clinical information and the injection protocol used to acquire the CT images graded the degree of contrast enhancement using a 5-point scoring system. The results for the different groups were statistically compared.

RESULTS

Contrast enhancement in the main phases for all organs was significantly more intense in group 2 than in groups 1 and 3. Cases in which pancreatic enhancement in the pancreatic phase was graded as excessive were more frequently observed in group 2. No statistically significant differences were observed between groups 1 and 3 in either quantitative or visual assessment for enhancement of any organ in any phase.

CONCLUSION

We recommend reducing the dose and rate of contrast material injection by at least 10% for elderly patients undergoing MDCT examination of the pancreatobiliary region.

Contrast Bolus Optimization for Cardiac 16-Slice Computed Tomography

OBJECTIVES

The aims of our study were to compare contrast injection protocols with contrast media containing 300 and 400 mg iodine per milliliter for optimal contrast enhancement in cardiac multidector row computed tomography (CT) and to evaluate the correlation of test bolus curve parameters with the final contrast density of the main bolus.

MATERIALS AND METHODS

Sixty patients with known or suspected coronary artery disease were included in a prospective double-blind study. Patients were randomized to 2 groups. Group 1 received 83 mL of a contrast medium (CM) containing 300 mg of iodine (Iomeron 300, Bracco Imaging SpA, Milan, Italy) at a flow rate of 3.3 mL/s, whereas group 2 received 63 mL of the same agent containing 400 mg of iodine (Iomeron 400) at a flow rate of 2.5 mL/s. The test bolus volumes were 20 mL and 15 mL, respectively. Imaging was performed using a 16-slice CT system (16DCT; Somatom Sensation 16, Siemens Medical Solutions, Forchheim, Germany). Contrast densities (Hounsfield Units [HU]) were determined in the cardiac chambers and in the main coronary arteries. The peak density and area under the curve of the test bolus were calculated for each patient.

RESULTS

The mean contrast densities of the coronary arteries were 259.1 +/- 46.7 HU for group 1 and 251.6 +/- 51.0 HU, for group 2. No noteworthy differences between groups were noted for density measurements in the cardiac chambers or for the ratio of right-to-left ventricle density. Whereas a positive correlation was noted for both groups between the area under the curve of the test bolus and the mean density of the main bolus, a positive correlation between peak density of the test bolus and mean density of the main bolus was noted only for group 1.

CONCLUSION

Equivalent homogenous enhancement of the ventricular cavities and coronary arteries to that obtained using a CM with standard iodine concentration (Iomeron 300) can be achieved with lower overall volumes of administered CM and reduced injection flow rates when a CM with high iodine concentration (Iomeron 400) is used.

MDCT angiography for evaluation of the complete vascular tree of hemodialysis fistulas

OBJECTIVE

The purpose of our study was to assess the clinical feasibility of MDCT angiography for evaluating hemodialysis arteriovenous fistulas (AVFs).

MATERIALS AND METHODS

MDCT angiography of the complete vascular trees of 36 failing AVFs or AVF-related complications (20 native and 16 polytetrafluoroethylene graft AVFs) was reviewed. The numbers and degrees of stenoses at the anastomoses, graft loops, and draining and central veins and the presence of aneurysms or thrombosis were recorded. Wilcoxon's signed rank test was used to compare the findings of MDCT angiography with those of digital subtraction angiography (DSA) (n = 10), surgery (n = 22), or both (n = 4) performed within 2-6 days. Kappa statistics were used to correlate the clinical feasibility of MDCT angiography assessed by two reviewers.

RESULTS

Among the 14 AVFs examined with both MDCT angiography and DSA, no significant difference was seen in the detection and grading (p = 0.317 to > 0.999) of stenoses at various segments of the entire vascular tree. Among the 36 AVFs examined, MDCT angiography also showed no significant difference from DSA or surgery in revealing vascular stenoses, aneurysms, and thromboses from the supplying artery to central veins (p = 0.317 to > 0.999). Overall, the sensitivity, specificity, positive and negative predictive values, and accuracy of MDCT angiography in lesion detection were 98.7%, 97.5%, 98.8%, 97.2%, and 98.3%, respectively. High image quality with superb interobserver correlation (kappa = 0.809 to > 0.999) validated the clinical feasibility of MDCT angiography for assessing AVFs.

CONCLUSION

MDCT angiography is clinically feasible for evaluating the complete vascular tree of failing AVFs and in showing uncommon complications, including brachial aneurysms and central vein lesions.

Gadolinium-enhanced MDCT angiography of the abdomen: feasibility and limitations

OBJECTIVE

The purpose of this study was to evaluate a protocol for gadolinium-enhanced MDCT angiography of the abdomen and to identify technical parameters that optimize image quality.

CONCLUSION

The degree of enhancement and image quality achieved using this gadolinium-enhanced MDCT angiography appear adequate for angiographic evaluation of the abdominal aorta and its major branches.

Multidetector row CT angiography of the abdominal aorta and lower extremities in patients with peripheral arterial occlusive disease: diagnostic accuracy and interobserver agreement

PURPOSE

To evaluate the accuracy of four channel multidetector row CT angiography (MDCTA) of the abdominal aorta and lower extremities arteries compared with digital subtraction angiography (DSA).

MATERIALS AND METHODS

In our prospective study 42 patients with peripheral vascular occlusive disease (27 M, 15 F, age range 40-79 years) underwent MDCTA and DSA within 5 days. Images were blindly interpreted by two radiologists. Maximum intensity projections (MIP), multiplanar (MPR) reformations, three-dimensional (3D) reconstructions as well as axial images were available for analysis of MDCTA. DSA were analyzed on hard copies.

RESULTS

Overall sensitivity and specificity of MDCTA were 93 and 95%, respectively, with positive and negative predictive values of 90 and 97%. Overall diagnostic accuracy was 94%. Normal arterial segments and 100% occlusions were correctly identified in all cases by MDCTA. Moderately stenotic segments interpretation in the calves appeared to be more controversial, but no statistical difference in accuracy of MDCTA in the infrapopliteal district arteries was noted with respect to accuracy in the more proximal arterial bed. Good to excellent interobserver and intraobserver agreement were observed, with k values greater than 0.80.

CONCLUSIONS

MDCTA of the abdominal aorta and lower extremities is an accurate imaging modality in clinical practice when compared with DSA.

Abdominal aortic aneurysms at multi-detector row helical CT: optimization with interactive determination of scanning delay and contrast medium dose

PURPOSE

To prospectively evaluate a technique for optimizing aortoiliac enhancement at multi-detector row helical computed tomography (CT) with both the scanning delay and contrast medium dose determined by using an interactive method.

MATERIALS AND METHODS

Forty-five patients with abdominal aortic aneurysm were randomized to undergo multi-detector row helical CT with either an interactive protocol (n = 23) or a standard protocol (n = 22). Scanning delays in all patients were determined with automated triggering. Patients in the standard protocol group received 150 mL of contrast medium intravenously at 4 mL/sec. The same injection rate was used for the interactive protocol group, but the dose was reduced with discontinuation of injection at start of scanning. Quantities of contrast medium used and contrast-enhanced aortic attenuation achieved were compared. Aortoiliac enhancement was evaluated qualitatively by using a five-point scale (1 = poor, 5 = excellent). Quantitative and qualitative data were analyzed with the two-tailed t test and Wilcoxon rank sum test, respectively, to determine significance of differences (P <.05).

RESULTS

Data from six patients were excluded because of technical errors. Data were analyzed from 20 patients in the interactive protocol group and 19 in the standard protocol group. Mean contrast medium volume was 107 mL +/- 20 (standard deviation) in the interactive protocol group and 148 mL +/- 3 in the standard protocol group (P <.001). Mean contrast-enhanced attenuation at initial, peak, and final measurements was 257 HU +/- 38, 285 HU +/- 46, and 269 HU +/- 54, respectively, for the interactive protocol group, and 261 HU +/- 65, 288 HU +/- 66, and 269 HU +/- 61 for the standard protocol group (P >.05). Mean qualitative enhancement scores for interactive and standard protocol groups were 4.47 and 4.44, respectively (P =.47).

CONCLUSION

The interactive method is a simple, efficient, and reproducible way to optimize aortoiliac enhancement while reducing contrast medium dose.

Detection of active colonic hemorrhage with use of helical CT: findings in a swine model

PURPOSE

To evaluate the feasibility of helical computed tomography (CT) as an imaging modality for depicting active colonic hemorrhage in a swine model.

MATERIALS AND METHODS

Controlled extravasation of contrast material-enhanced blood (CEB) from 140 to 180 HU and at varying rates (0.3-1.0 mL/min) was performed during a 30-second period by using a microcatheter system placed within the descending colon of 14 swine. CEB was immediately followed by extravasation of unopacified blood at the same location and rate during serial helical CT imaging of the extravasation site. Region-of-interest analysis allowed quantification of the dilution of extravasated CEB as a function of time that was then modeled mathematically based on iodine mass and volume balances. Nonlinear least squares analysis was performed to optimize fitting of the model to experimental data, with a maximum regression value (R2) of 1.0 indicating a perfect fit. This model enabled the computer simulation of CT imaging of multiple combinations of bleeding rates and CEB attenuation to determine the sensitivity of helical CT for depicting active colonic bleeding.

RESULTS

Sixteen swine examinations yielded 16 CEB dilution curves. An excellent fit of the model to each dilution curve was achieved, as indicated by a mean R2 value of 0.8402. Swine examinations alone showed that targeted CT could depict CEB as low as 111 HU extravasating at a rate of 0.3 mL/min. Simulations that were based on helical CT images with 5-mm collimation reconstructed every 3 mm and that used the model indicated bleeding rates below 0.4 mL/min are detectable, provided peak aortic enhancement reaches 100 HU.

CONCLUSION

Conservatively, helical CT has the potential to depict active colonic hemorrhage at rates of 0.5 mL/min or less.

Peak contrast enhancement in CT and MR angiography: when does it occur and why? Pharmacokinetic study in a porcine model

PURPOSE

To investigate pharmacokinetic and physiologic factors that determine the time to peak intravenous contrast medium enhancement in computed tomographic (CT) and magnetic resonance (MR) angiography in the porcine mid-abdominal aorta.

MATERIALS AND METHODS

Four pigs were imaged repeatedly in seven to eight sets: For each set, 20 dynamic CT scans were obtained at a fixed aortic level after intravenous injection of contrast medium. From a physiologically based compartment model, aortic contrast enhancement curves were generated by varying contrast medium injection duration from 1 to 40 seconds. Contrast enhancement curves and times to peak aortic enhancement from the experiment and model were compared. Time to peak aortic enhancement obtained from the injection with the shortest duration was considered the time to peak test bolus contrast enhancement. Mathematic and pharmacokinetic analyses were performed to investigate factors that determine peak enhancement.

RESULTS

Empiric and compartmental model times to peak aortic enhancement were in good agreement. Time to peak aortic enhancement corresponded to the weighted sum of injection duration and time to peak test bolus enhancement. With increasing injection duration, the relative contribution of injection duration to peak aortic enhancement time increased. When injection duration was longer than time to peak test bolus enhancement, time to peak aortic enhancement increased linearly with injection duration and occurred shortly after completion of injection. However, when injection duration was shorter than time to peak test bolus enhancement, time to peak aortic enhancement was determined predominantly by time to peak test bolus enhancement and only gradually increased with injection duration.

CONCLUSION

Time to peak aortic enhancement is determined by the relative contributions of injection duration and contrast medium traveling time and may well be explained by contrast medium volumetric inflow and recirculation physiology.

Use of high concentration contrast media: principles and rationale-vascular district

Optimal contrast medium delivery remains a crucial issue in CT angiography and it will become even more critical with continuously evolving, faster CT scanner technology. This review article first explains the fundamentals of arterial enhancement using mathematical models of early contrast medium dynamics. The relationship of contrast medium volume, injection flow rates and injection duration are explicitly illustrated. Next, current techniques of contrast medium application are reviewed, with particular attention to methods of accurate timing of the scanning delay (test-bolus and automated bolus triggering), tools for automated saline-flushing of the veins (double-syringe power injectors) and the use of high-concentration contrast medium. From there, rational CT angiographic injection protocols for a wide range of selectable acquisition times for 4-, 8- and 16-channel MDCT are proposed.

Hepatic arterial phase MR imaging with automated bolus-detection three-dimensional fast gradient-recalled-echo sequence: comparison with test-bolus method

Sixty-two patients underwent magnetic resonance (MR) imaging of the liver with the automated contrast material bolus-detection technique. Arterial phase MR images were assessed quantitatively and qualitatively. In 23 patients, a test bolus of contrast material was injected intravenously before dynamic MR imaging. There was good correlation and agreement between delay times estimated with both timing methods. Eighty-three percent of arterial phase images obtained with automated contrast material bolus detection were optimal. There was good correlation and agreement between delay times estimated with both timing methods. Optimal hepatic arterial phase MR images can be obtained routinely with automated detection of a contrast material bolus.

CT angiography of the arterial system

CTA has become an important diagnostic tool in the evaluation of vascular diseases in virtually all parts of the body. Whereas CTA is able to provide images depicting exquisite anatomic detail, careful scanning technique and selection of scan parameters are critical for high quality studies. The choices to be made when prescribing a scan can seem daunting at first, but if one applies the principles outlined previously, CTA can be a relatively easy, fast, and safe diagnostic technique that is effective in the majority of patients with vascular disease.

Infrarenal abdominal aortic aneurysms at multi-detector row CT angiography: intravascular enhancement without a timing acquisition

In 70 patients referred for evaluation of aortoiliac aneurysm disease, multi-detector row computed tomography was performed with a uniform 25-second delay from the initiation of intravenous administration of a 150-mL bolus of contrast material at 4 mL/sec. In all patients, adequate enhancement (>200 HU) of the aorta and intense enhancement of iliofemoral runoff was achieved without venous contamination.

Accuracy of predicting and controlling time-dependent aortic enhancement from a test bolus injection

PURPOSE

The purpose of this work was to determine the accuracy of predicting arterial enhancement from peripheral versus central venous test bolus injections at CT angiography (CTA).

METHOD

In 40 patients with abdominal aortic aneurysms, aortoiliac enhancement profiles were predicted by mathematical deconvolution of the time-attenuation response to a 16 ml test bolus injection. Injection sites were either a cubital vein (n = 20) or a central venous injection site (n = 20). The accuracy of predicting enhancement was quantified as the "off-predicted deviation" (calculated as mean squared differences between observed minus predicted enhancement values) in all patients.

RESULTS

Off-predicted deviation was significantly smaller in the central venous injection group (17 +/- 6 HU) than the peripheral injection group (33 +/- 18 HU) (p < 0.001).

CONCLUSION

Arterial enhancement at CTA can be mathematically predicted and controlled more accurately if a central venous injection site is used. Automated saline flushing of the veins might improve the accuracy of the mathematical model for peripheral injections.

Gadolinium-enhanced arterial-phase MR imaging of hypervascular liver tumors: comparison between tailored and fixed scanning delays in the same patients

The purpose of this study was to compare in the same patients tailored and fixed scanning delays during gadolinium-enhanced arterial-phase magnetic resonance imaging of hypervascular liver tumors. Tailored scanning delays were obtained with automated region of interest threshold triggering. A delay of 23 seconds between the start of contrast material injection and imaging was used for fixed delay examinations. Quantitative and qualitative evaluation was performed in 21 patients with normal cardiac function referred for MR assessment of hypervascular liver tumors. In the tailored examinations, the median time delay between the start of contrast material injection and the start of magnetic resonance imaging was 21 seconds (range, 18-34 seconds). The median tumor-to-liver contrast during tailored examinations was 19.1 versus 14.7 during fixed delay examinations. This difference, however, was not significant. Similarly, the enhancement in the aorta, the portal vein, the liver, and the tumor did not differ significantly between examinations performed with tailored and fixed delays. It is concluded that in our group of patients with hypervascular liver tumors and normal cardiac function, no significant improvement in tumor-to-liver contrast and enhancement during the arterial phase was found when gadolinium-enhanced magnetic resonance imaging was performed with a tailored scanning delay rather than with a fixed delay.

Improved uniformity of aortic enhancement with customized contrast medium injection protocols at CT angiography

PURPOSE

To compare the uniformity of aortoiliac opacification obtained from uniphasic contrast medium injections versus individualized biphasic injections at computed tomographic (CT) angiography.

MATERIALS AND METHODS

Thirty-two patients with an abdominal aortic aneurysm underwent CT angiography. In 16 patients (group 1), 120 mL of contrast material was administered at a flow rate of 4 mL/sec. In the other 16 patients (group 2), biphasic injection protocols were computed by using mathematic deconvolution of each patient's time-attenuation response to a standardized test injection. Attenuation uniformity was quantified as the "plateau deviation" of enhancement values, which were calculated as the SD of the time-contiguous attenuation values observed during the 30-second scanning period.

RESULTS

Group 2 patients received between 77 and 165 mL (mean, 115 mL) of contrast medium. Initial flow rates ranged from 4.1 to 10.0 mL/sec (mean, 6.8 mL/sec) for the first 4-6 seconds; continuing flow rates ranged from 2.0 to 4.8 mL/sec (mean, 3.1 mL/sec) for the remaining 24-26 seconds. The plateau deviation was significantly smaller in group 2 patients (19 HU) versus group 1 patients (38 HU, P <.001).

CONCLUSION

At CT angiography, tailored biphasic injections led to more uniform aortoiliac enhancement, compared with standard uniphasic injections of contrast medium.

Renovascular disease

The gold standard for the diagnosis of renal artery stenosis is angiography, with response to treatment the proof of its significance. Non-invasive methods of investigation are required and are now available including functional imaging, ultrasound, CT and MR angiography and the merits and limitations of these tests are discussed.

Mathematical analysis of arterial enhancement and optimization of bolus geometry for CT angiography using the discrete fourier transform

PURPOSE

The goal of this work was to develop a clinically applicable mathematical algorithm to analyze and optimize individual arterial enhancement in CT angiography (CTA).

METHOD

Assuming a time-invariant linear system, the discrete Fourier transform was used to calculate the transfer function of the system ("patient function") from the arterial time-attenuation response to a test bolus. The patient function was subsequently used to predict aortic enhancement in five select patients and to calculate optimized biphasic injection protocols in two of these patients undergoing CTA of the abdominal aorta.

RESULTS

Arterial time-attenuation curves were accurately predicted in all patients. Optimized biphasic contrast agent injection protocols resulted in uniform aortic enhancement at the predefined level over the entire scanning period in both subjects despite markedly different contrast agent volumes and injection rates used.

CONCLUSION

Fourier analysis of the time-attenuation response to a test bolus is a simple and feasible approach to optimize arterial enhancement in CTA.

The effects of apnea on timing examinations for optimization of gadolinium-enhanced MRA of the thoracic aorta and arch vessels

PURPOSE

Our purpose was to determine the effects of apnea during end-inspiration compared with free breathing on timing examinations performed to optimize gadolinium-enhanced 3D MR angiography (MRA) of the thoracic aorta and arch vessels.

METHOD

Thirty patients referred for gadolinium-enhanced 3D MRA of the thoracic aorta and branch vessels underwent two timing examinations: one performed during free breathing and one during apnea at end-inspiration to replicate more closely the respiratory pattern used to obtain 3D MRA. For each, axial images at the level of the proximal neck were acquired every 2 s for 40 s, during which time 1 ml of gadolinium contrast agent followed by 20 ml of saline was infused at 2 ml/s. The time to peak arterial enhancement (Ta), time to first jugular venous enhancement (Tj), and arterio-venous window (time from peak arterial enhancement to first jugular venous enhancement; AV) were compared for the two examinations in each patient.

RESULTS

Overall there was no statistically significant difference in Ta, Tj, or AV between examinations performed during free breathing and apnea in end-inspiration, although a trend to delayed circulation times was observed with apnea (p = 0.2-0.3). In five patients (17%), the difference in Ta between free breathing and apnea was 4 s; in three patients (10%), the difference was 6 s.

CONCLUSION

Circulation times determined during apnea at end-inspiration may differ from those obtained during free breathing by as much as 6 s in an individual patient. This difference may account for inappropriately timed gadolinium-enhanced MR angiograms performed with timing examinations, especially when very short acquisition times and low doses of gadolinium (20 ml) are used.

Spiral CT: vascular applications

Recent technical advances in CT have renewed interest in the development of CT angiography (CTA). CT angiography is a minimally invasive method of visualising the vascular system and is becoming an alternative to conventional arteriography in some situations. Spiral technology allows a volume of data to be obtained on a single breath-hold with no respiratory misregistration. Fast machines with second or subsecond acquisition times mean the images are obtained while there are high circulating levels of contrast medium giving peak vascular opacification from a peripheral intravenous injection. Accurate timing will ensure either the arterial or venous phase is imaged. Multiple overlapping axial images can be obtained from the data set with no increase in radiation dose to the patient and from these scans computer generated multiplanar and 3D images are obtained which can be viewed from numerous angles. CT angiography can be performed more quickly, less invasively and at reduced cost compared to conventional angiography.

Spiral CT angiography of the renal arteries: should a scan delay based on a test bolus injection or a fixed scan delay be used to obtain maximum enhancement of the vessels?

PURPOSE

The purpose of this work was to assess the optimal scan delay for spiral CT angiography (SCTA) of the renal arteries in achieving optimal vascular contrast enhancement and to compare the utility of a delay based on these bolus injection versus that of a fixed scan delay.

METHOD

Seventy patients underwent renal artery SCTA with a 140 ml bolus of contrast agent injected a 3 ml/s. In 35 patients (Group A), a fixed scan delay of 27 s was used; in the other 35 (Group B), the scan delay was based on the transit time (TTest) of a test bolus injection. The scan delays in this group were set at TTest + 5 s (n = 5), TTest + 10 s (n = 8), TTest + 15 s (n = 4), or TTest + 20 s (n = 18). For all 70 patients, the time intervals between TRA (time to scanning the renal arteries) and TMax (time to maximum aortic enhancement after 140 ml bolus injection) were calculated, after which it was determined in which group of patients TRA occurred closest to TMax. Linear regression and mean squared error (MSE) were used for statistical analysis.

RESULTS

For Group A, mean TRA and TMax were 38 and 50 s, respectively. Mean (TRA - TMax) was -12 s with MSE of 185.76. For Group B, mean TRA and Tmax were 45 and 52 s. Mean (TRA - TMax) values were -15, -12, -11, and -1 s for scan delays of TTEST + 5 s, TTEST + 10 s, TTest + 15 s, and TTEST + 20 s, respectively, with MSEs of 253.80, 158.00, 137.50, and 30.00.

CONCLUSION

SCTA of the renal arteries was best performed with a scan delay of TTEST + 20 s. However, analysis of our data showed that similar results could be expected with a delay of 44 s.